Pfizer
PFE
PFE
2,071 hedge funds and large institutions have $145B invested in Pfizer in 2017 Q1 according to their latest regulatory filings, with 114 funds opening new positions, 856 increasing their positions, 908 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.11% more ownership
Funds ownership: 74.69% → 74.81% (+0.11%)
6% less repeat investments, than reductions
Existing positions increased: 856 | Existing positions reduced: 908
25% less call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.99B
Holders
2,071
Holding in Top 10
180
Calls
$1.49B
Puts
$1.99B
Top Buyers
| 1 | +$14.3B | |
| 2 | +$348M | |
| 3 | +$335M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$242M |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
+$156M |
Top Sellers
| 1 | -$368M | |
| 2 | -$331M | |
| 3 | -$253M | |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$178M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$164M |